| scholarly article | Q13442814 |
| P50 | author | Nancy D Merner | Q55691940 |
| P2093 | author name string | Anna L W Huskey | |
| Madison R Bishop | |||
| Sophonie M Omeler-Fenaud | |||
| P2860 | cites work | ClinVar: public archive of interpretations of clinically relevant variants | Q28603051 |
| Developing and evaluating polygenic risk prediction models for stratified disease prevention | Q30251440 | ||
| Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
| Application of Panel-Based Tests for Inherited Risk of Cancer | Q34556755 | ||
| Inherited predisposition to breast cancer among African American women | Q34983596 | ||
| Breast cancer genetics in African Americans | Q35030244 | ||
| Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry. | Q53695908 | ||
| Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing | Q58797082 | ||
| The effects of genomic germline variant reclassification on clinical cancer care | Q61796823 | ||
| Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry | Q81370600 | ||
| Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel | Q85247141 | ||
| Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing | Q87060003 | ||
| Establishment of the Alabama Hereditary Cancer Cohort - strategies for the inclusion of underrepresented populations in cancer genetics research | Q89371264 | ||
| Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients | Q91701406 | ||
| A research-based gene panel to investigate breast, ovarian and prostate cancer genetic risk | Q92638741 | ||
| Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients | Q92968809 | ||
| Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer. | Q35736188 | ||
| Gene-panel sequencing and the prediction of breast-cancer risk | Q36175072 | ||
| Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women | Q36176860 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Germline truncating mutations in both MSH2 and BRCA2 in a single kindred | Q36694501 | ||
| Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer | Q36946787 | ||
| BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers | Q37002955 | ||
| The Clinical Significance of Unknown Sequence Variants in BRCA Genes. | Q37334266 | ||
| Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women. | Q38691342 | ||
| A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery | Q38844517 | ||
| High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients. | Q39029780 | ||
| Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India | Q40890323 | ||
| Germline RECQL mutations are associated with breast cancer susceptibility | Q41010238 | ||
| InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines | Q41830006 | ||
| Use of panel tests in place of single gene tests in the cancer genetics clinic. | Q45079192 | ||
| Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. | Q45985357 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P304 | page(s) | e0238295 | |
| P577 | publication date | 2020-08-31 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Gene panel screening for insight towards breast cancer susceptibility in different ethnicities | |
| P478 | volume | 15 |
Search more.